MICROBIAL SKIN COLONIZATION IN PATIENTS WITH ATOPIC DERMATITIS: ASSOCIATION WITH IMMUNOLOGICAL PARAMETERS AND CLINICAL DISEASE SEVERITY

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by impaired epidermal barrier function, immune dysregulation, and altered microbial ecology. In recent decades, there has been a steady increase in its prevalence, making AD one of the most pressing issues in dermatology. The aim of this study was to comprehensively assess bacterial skin colonization in patients with AD using real-time quantitative PCR and to analyze its relationship with clinical and immunological parameters of the disease.

A prospective study included 110 patients with AD and 86 apparently healthy individuals. Disease severity was assessed using the SCORAD index; total IgE levels and complete blood count were measured, and quantification of skin microbiota was performed by real-time PCR. The results revealed a significant increase in bacterial load in the AD group compared to controls: total bacterial mass was 32 times higher, while Staphylococcus spp. and Staphylococcus aureus were 100 times higher. The concentration of Streptococcus spp. did not differ significantly.

A strong positive correlation was found between the SCORAD index, total IgE level, absolute eosinophil count, and the quantity of total bacterial mass, Staphylococcus spp., and S. aureus, whereas a weak negative correlation was observed for Streptococcus spp. Patients with severe AD had significantly higher IgE levels.

The obtained data confirm the central role of S. aureus and microbial dysbiosis in the pathogenesis of AD. The established threshold values of bacterial load (total bacterial mass > 5.0 log copies/mL, S. aureus > 4.0 log copies/mL) may serve as objective criteria for prescribing targeted antimicrobial therapy.

1. Weidinger S., Novak N. Atopic dermatitis. Lancet, 2016, Vol. 387, pp. 1109-1122.

2. Bieber T. Atopic dermatitis. N Engl J Med . 2008 Apr 3;358(14):1483-94.

3. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab . 2015:66 Suppl 1:8-16.

4. Laughter M.R., Maymone M.B.C., Mashayekhi S., Arents B.W.M., Karimkhani C., Langan S.M. et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017. Br J Dermatol, 2021, Vol. 184, no. 2, pp. 304–309.

5. Tao Z., Jinho Y., Min H.O., Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res, 2011, Vol. 3, no. 2, pp. 67-73.

6. Criado P.R., Miot Hélio A., Bueno-Filho R., Ianhez M. et al. Update on the pathogenesis of atopic dermatitis.An Bras Dermatol . 2024 Nov-Dec;99(6):895-915.

7. Czarnowicki T., Krueger J., Guttman-Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march. J Allergy Clin Immunol, 2017, Vol. 139, pp. 1723–1734.

8. Montero-Vilchez T., Segura-Fernández-Nogueras M.V., Pérez-Rodríguez I., Soler-Gongora M., Martinez-Lopez A., Fernández-González A., Molina-Leyva A., Arias-Santiago S. Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity. J Clin Med, 2021, Vol. 10, no. 2, p. 359.

9. Chernushevich D.D., Elisyutina O.G., Fedenko E.S. Skin microbiome and modern treatment options for complicated forms of atopic dermatitis. Russ J Allergy, 2023, Vol. 20, no. 1, pp. 63-73.

10. Paller A.S., Kong H.H., Seed P., Naik S., Scharschmidt T.C., Gallo R.L., Luger T., Irvine A.D. The microbiome in patients with atopic dermatitis. J. Allergy Clin. Immunol., 2019, Vol. 143, pp. 26-35.

11. Kong H.H., Oh J., Deming C., Conlan S., Grice E.A., Beatson M.A., et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012 May;22(5):850-9.

12. Meylan P., Lang C., Mermoud S., Johannsen A., Norrenberg S., Hohl D., Vial Y., Prod'hom G., Greub G., Kypriotou M., Christen-Zaech S. Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy. J Investig Dermatol, 2017, Vol. 137, pp. 2497–2504.

13. Leyden J.J., Marples R.R., Kligman A. M. Staphylococcus aureus in the lesions of atopic dermatitis Br J Dermatol.1974 May;90(5):525-30.

14. Langer K., Breuer K., Kapp A., Werfel T. Staphylococcus aureus-derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis.Exp Dermatol . 2007 Feb;16(2):124-9.

15. Bunikowski R., Mielke M. E., Skarabis H., Worm M., Anagnostopoulos I., Kolde G., Wahn U., Renz H. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol. 2000 Apr;105(4):814-9.

16. Kobayashi T., Glatz M., Horiuchi K., Kawasaki H., Akiyama H..Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.mmunity . 2015 Apr 21;42(4):756-66.

17. Meylan P., Lang C., Mermoud S., Johannsen A., Norrenberg S. Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy.J Invest Dermatol. 2017 Dec;137(12):2497-2504.

18. Grice E.A., Segre J.A. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244-53.

19. Kong H.H. Skin microbiome: genomics-based insights into the diversity and role of skin microbes.Trends Mol Med. 2011 Mar 4;17(6):320–328.

20. Savcheno N.V., Kornilov D.O., Simarzina V.M., Tryapitsyn M.A., Nechaeva D.M., Bekhter A.A., Itani T.M., Zornikov D.L., Voroshilina E.S. Pilot study on real-time PCR capabilities for the detection of opportunistic microorganisms in skin microbiome samples. USMU Med Bull, 2024, no. 2, pp. 61-74.

21. Kunz B., Oranje A.P., Labreze L., Stalder J.F., Ring J., Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatol., 1997, Vol. 195, pp. 10–19.

22. Russian Society of Dermatovenerologists and Cosmetologists; Russian Association of Allergists and Clinical Immunologists; Union of Pediatricians of Russia. Atopic Dermatitis: Clinical Guidelines, 2023

23. Sokolova T.V., Safonova L.A., Klivitskaya N.A. Medical mistakes in tactics of management of patients with atopic dermatitis associated with opportunistic yeast microflora infection. Russ J Clin Dermatol Venereol, 2016, Vol. 15, no. 2, pp. 59-71.

24. Katoh N., Ohya Y., Ikeda M, Ebihara T., Katayama I. et all. Japanese guidelines for atopic dermatitis 2020.Allergol Int . 2020 Jul;69(3):356-369.

25. Arzumanyan V.G., Magarshak O.O., Semenov B.F. Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. Bull Exp Biol Med, 2000, Vol. 129, pp. 601–604.

26. Edslev S. M., Agner T., Andersen P.S. Skin Microbiome in Atopic Dermatitis.Acta Derm Venereol . 2020 Jun 9;100(12):adv00164.